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        Activated CD4  +   T cells diff   erentiate into at 
least three distinct eff  ector subsets as defi  ned by 
their patterns of cytokine production (  1  –  4  ). 
Th1 cells produce IFN-     and lymphotoxin and 
play a critical role in protective immunity 
against intracellular pathogens (  1  –  4  ). Th2 cells 
produce IL-4, -5, and -13 and are essential for 
the expulsion of parasites (  1  –  4  ). Newly identi-
fi  ed Th17 cells produce IL-17A and -17F and 
play a pathogenic role in a variety of autoim-
mune diseases (  1  –  5  ). Recently, it has been re-
ported that IL-21 is another cytokine highly 
produced by Th17 cells and that it promotes 
the development of Th17 cells (  6  –  9  ). 
  IL-21 is a four-helix-bundle type I cytokine 
with signifi  cant homology to IL-2, -15, and -4 
(  10  –  12  ). IL-21 has been demonstrated to be 
  expressed in Th2 cells (  13  ), follicular B helper 
T cells (  14  ), and NK T cells (  15  ) and to exhibit 
pleiotropic eff  ects on the proliferation, diff  er-
entiation, and eff  ector function of T, B, NK, 
and dendritic cells (  10  –  12  ). In vivo, it has been 
shown that IL-21 is involved in several autoim-
mune disease models. For example, lymphopenia 
and compensatory IL-21 –  mediated homeostatic 
expansion of lymphocytes has been reported to 
be involved in the development of autoimmu-
nity in NOD mice (  16  ). The excessive produc-
tion of IL-21 has been shown to be associated 
with the development of high titers of autoan-
tibodies and a lupus-like pathology in   Sanroque   
mice (  17  ). Furthermore, a blockade of IL-21 
signaling has been demonstrated to ameliorate 
mouse models of rheumatoid arthritis and lupus 
(  18, 19  ). However, the characteristic of IL-21  –
  producing CD4  +   T cells, especially in their re-
lation to Th17 cells, is still unknown because a 
single-cell analysis of IL-21  –  producing cells has 
not been achieved yet. 
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  It has recently been shown that interleukin (IL)-21 is produced by Th17 cells, functions as 
an autocrine growth factor for Th17 cells, and plays critical roles in autoimmune diseases. 
In this study, we investigated the differentiation and characteristics of IL-21  –  producing 
CD4  +   T cells by intracellular staining. Unexpectedly, we found that under Th17-polarizing 
conditions, the majority of IL-21  –  producing CD4  +   T cells did not produce IL-17A and -17F. 
We also found that IL-6 and -21 potently induced the development of IL-21  –  producing 
CD4  +   T cells without the induction of IL-4, IFN-    , IL-17A, or IL-17F production. On the 
other hand, TGF-     inhibited IL-6  –   and IL-21  –  induced development of IL-21  –  producing 
CD4  +   T cells. IL-2 enhanced the development of IL-21  –  producing CD4  +   T cells under Th17-
polarizing conditions. Finally, IL-21  –  producing CD4  +   T cells exhibited a stable phenotype of 
IL-21 production in the presence of IL-6, but retained the potential to produce IL-4 under 
Th2-polarizing conditions and IL-17A under Th17-polarizing conditions. These results 
suggest that IL-21  –  producing CD4  +   T cells exhibit distinct characteristics from Th17 cells 
and develop preferentially in an IL-6  –  rich environment devoid of TGF-    , and that IL-21 
functions as an autocrine growth factor for IL-21  –  producing CD4  +   T cells. 1370 CHARACTERIZATION OF IL-21  –  PRODUCING HELPER T CELLS | Suto et al.
IL-21 functions as an autocrine growth factor for Th17 cells 
(  6  –  9  ). We also found that IL-21 was produced by activated 
CD4  +   T cells under Th17-polarizing conditions (in the pres-
ence of IL-6, TGF-    , anti  –  IL-4 mAb, and anti  –  IFN-     mAb) 
much greater than under Th2-polarizing conditions or under 
Th1-polarizing conditions (  Fig. 1 A  ).   However, it was still 
unclear whether IL-21 is actually produced by Th17 cells and 
what is the developmental and phenotypic characteristic of 
IL-21  –  producing CD4  +   T cells because IL-21 production 
has not been determined at single-cell levels as yet. To ad-
dress these issues, we established the intracellular cytokine 
staining of IL-21. We fi  rst generated several IL-21  –  produc-
ing Ba/F3 cell clones using a bicistronic retrovirus system and 
measured the levels of IL-21 in the culture supernatants by 
ELISA. Among these clones, Ba/F3-IL-21-GFP #6 cells 
produced a signifi  cant amount of IL-21 (  Fig. 1 B  , left), and 
we used this clone as a positive control for intracellular stain-
ing of IL-21. To detect intracellular IL-21, we used mouse 
IL-21R/human Fc-chimera (IL-21R-Fc) to capture IL-21 
and anti  –  human Fc PE to visualize IL-21  –  IL-21R-Fc com-
plexes. When cells were stained by this method, positive sig-
nals were detected in Ba/F3-IL-21-GFP #6 cells, but not in 
control Ba/F3-empty-GFP cells (  Fig. 1 B  , right). In the ab-
sence of IL-21R-Fc, no positive signal was detected (  Fig. 1 B  , 
right), confi  rming the correct detection of IL-21 by the in-
tracellular staining. 
  By using the intracellular staining of IL-21, we examined 
IL-21  –  producing CD4  +   T cells at single-cell levels. When 
  In this study, by establishing the intracellular staining of 
IL-21, we found that although IL-21  –  producing CD4  +   T cells 
developed preferentially under Th17-polarizing conditions, a 
considerable number of IL-21  –  producing CD4  +   T cells were 
negative for intracellular IL-17A and -17F. We also found that 
IL-6 potently induced the development of IL-21  –  producing 
CD4  +   T cells without the induction of IL-4, IFN-    , IL-17A, 
or IL-17F production. On the other hand, TGF-     inhibited 
the IL-6  –  induced development of IL-21  –  producing CD4  +   
T cells. In addition, IL-2 signifi  cantly enhanced the develop-
ment of IL-21  –  producing CD4  +   T cells under Th17-polarizing 
conditions. IL-21 itself also induced the development of IL-
21  –  producing CD4  +   T cells. IL-21  –  producing CD4  +   T cells 
exhibited a stable phenotype of IL-21 production in the pres-
ence of IL-6, but still had a potential to produce IL-4 under 
Th2-polarizing conditions and IL-17A under Th17-polarizing 
conditions. Our results suggest that IL-21  –  producing CD4  +   
T cells exhibit distinct characteristics from Th17 cells, that IL-21  –
  producing CD4  +   T cells develop preferentially in an IL-6-rich 
environment devoid of TGF-    , and that IL-21 functions as an 
autocrine growth factor for IL-21  –  producing CD4  +   T cells. 
    RESULTS   
  IL-21  –  producing CD4  +   T cells develop preferentially 
under Th17-polarizing conditions, but the majority 
of them are negative for intracellular IL-17A and -17F 
  Recently, it has been shown that Th17 cells produce a large 
amount of IL-21 compared with Th2 and Th1 cells, and that 
    Figure 1.     Establishment of a single-cell analysis of IL-21  –  producing cells.   (A) IL-21 and -17A are produced by activated CD4  +   T cells under Th17-
polarizing conditions. Purifi  ed CD4  +   T cells from lymph nodes of C57BL/6 mice were stimulated with anti-CD3 mAb/anti-CD28 mAb under Th1-, Th2-, 
and Th17-polarizing conditions. On day 5, 10  6   cells were restimulated with anti-CD3 mAb/anti-CD28 mAb for 24 h. The levels of cytokines in the culture 
supernatants were measured by ELISA. Data are the means   ±   the SD from four independent experiments. *, P   <   0.01. (B) Establishment of a single-cell 
analysis of IL-21  –  producing cells. Ba/F3 cells were infected with pMX-IL-21-IRES-GFP retrovirus or control retrovirus (pMX-IRES-GFP). Nine clones of 
pMX-IL-21-IRES-GFP retrovirus-infected Ba/F3 cells (Ba/F3-IL-21-GFP cells) and one clone of control retrovirus-infected Ba/F3 cells (Ba/F3-GFP cells) 
were selected by limiting dilution. IL-21 in the culture supernatants was measured by ELISA (left). Ba/F3-GFP cells and Ba/F3-IL-21-GFP clone #6 cells 
were fi  xed, permeabilized, and incubated with IL-21R-Fc or PBS. After washing, cells were visualized with anti-Fc PE (right).     JEM VOL. 205, June 9, 2008 
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ment of IL-21  –  producing CD4  +   T cells. Naive CD4  +   T cells 
were stimulated with anti-CD3 mAb/anti-CD28 mAb in the 
presence of IL-6, anti  –  IL-4 mAb, and anti  –  IFN-     mAb with 
or without TGF-    . We found that IL-6 together with the 
blocking antibodies to IL-4 and IFN-     strongly induced the 
development of IL-21  –  producing CD4  +   T cells without 
the induction of IL-4, IFN-    , IL-17A, or IL-17F production 
(  Fig. 3 A  ).   Furthermore, unexpectedly, TGF-     inhibited the 
development of IL-21  –  producing CD4  +   T cells in a dose-
dependent manner (  Fig. 3 A  ). Measurement of IL-21 levels 
in the supernatants confi  rmed the TGF-      –  mediated inhibi-
tion of IL-21 production (  Fig. 3 B  ). TGF-     also inhibited 
the development of IL-21  –  producing CD4  +   T cells under 
FACS-sorted naive CD4  +   T cells (CD44  low   CD25        CD4  +   
T cells) were stimulated with anti-CD3 mAb/anti-CD28 
mAb under Th1-, Th2-, and Th17-polarizing conditions, 
IL-21  –  producing cells were detected under Th17-polarizing 
conditions with a high frequency and under Th2-polarizing 
conditions with a moderate frequency (  Fig. 2  ), which is 
consistent with the levels of IL-21 in the supernatants of 
activated CD4  +   T cells under the corresponding culture 
conditions (  Fig. 1 A  ).   Under Th2-polarizing conditions, a 
signifi  cant number of IL-4  –  producing cells simultaneously 
produced IL-21 and   >  70% of IL-21  –  producing CD4  +   T cells 
were positive for intracellular IL-4 (  Fig. 2  ). Under Th17-
  polarizing conditions, a signifi  cant number of IL-17A- and 
IL-17F  –  producing cells also simultaneously produced IL-21, 
but   >  60% of IL-21  –  producing CD4  +   T cells were negative 
for intracellular IL-17A and -17F (  Fig. 2  ). IL-21  –  producing 
CD4  +   T cells under Th17-polarizing conditions were also 
negative for intracellular IL-4 and IFN-     (  Fig. 2  ). These re-
sults suggest that although IL-21  –  producing CD4  +   T cells 
develop preferentially under Th17-polarizing conditions, the 
majority of IL-21  –  producing CD4  +   T cells do not produce 
IL-17A or -17F. 
  IL-6 induces, but TGF-     inhibits, the development 
of IL-21  –  producing CD4  +   T cells 
  Because IL-21  –  producing CD4  +   T cells developed preferen-
tially under Th17-polarizing conditions as compared with 
Th1- or Th2-polarizing conditions (  Fig. 1 A   and   Fig. 2  ), we 
next examined the role of IL-6 and TGF-     in the develop-
    Figure 2.     CD4  +   T cells producing IL-21, but not IL-17A/IL-17F, are 
present under Th17-polarizing conditions.  Naive  CD4 +   T cells from 
lymph nodes of C57BL/6 mice were stimulated with anti-CD3 mAb/anti-
CD28 mAb under Th1-, Th2-, and Th17-polarizing conditions for 5 d. Cells 
were evaluated for the expression of the indicated cytokines by intracel-
lular cytokine staining as described in the Materials and methods. Data 
are representative of three independent experiments.     
    Figure 3.     IL-6 induces, but TGF-     inhibits, the development of 
IL-21  –  producing CD4  +   T cells.   (A and B) Naive CD4  +   T cells from C57BL/6 
mice were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence 
of  10   μ g/ml  anti – IL-4  mAb  and  10   μ g/ml  anti – IFN-    mAb (neutral condi-
tion) with or without 100 ng/ml IL-6. Where indicated, 0.2  –  2 ng/ml TGF-    
was added. (A) 4 d later, cells were stimulated with PMA/ionomycin, and 
intracellular staining for the indicated cytokines was performed. Shown 
are representative FACS profi  les from three independent experiments. 
(B) 4 d later, cells were washed and stimulated with PMA/ionomycin for 
8 h at 2   ×   10  6   cells/ml. The levels of IL-21 in the culture supernatants 
were measured by ELISA. Data are the mean   ±   the SD (  n   = 3). *, P   <   0.05; 
**,  P   <   0.01.   1372 CHARACTERIZATION OF IL-21  –  PRODUCING HELPER T CELLS | Suto et al.
  Smad3 is involved in TGF-      –  mediated inhibition 
of IL-21  –  producing CD4  +   T cells 
  Smad2 and Smad3 are phosphorylated by TGF-     receptor 
and heterodimerize with Smad4 (  23, 24  ). The activated Smad 
complex then translocates into the nucleus and regulates 
the transcription of target genes (  23, 24  ). We then used the 
mice lacking Smad3 (Smad3      /      mice) to determine whether 
Smad3 is required for the TGF-      –  mediated suppression of 
IL-21  –  producing CD4  +   T cells. Purifi  ed CD4  +   T cells from 
WT mice or asymptomatic Smad3      /      mice, in the latter of 
which lymph node CD4  +   T cells exhibit a normal phenotype 
regarding the activation markers such as CD69 (unpublished 
data) (  25  ), were stimulated with anti-CD3 mAb/anti-CD28 
mAb in the presence of IL-6, anti  –  IL-4 mAb, anti  –  IFN-     
mAb, and anti  –  IL-2 mAb with or without TGF-     and the 
development of IL-21  –  producing CD4  +   T cells and Th17 
cells was evaluated by intracellular staining. As shown in   Fig. 5  , 
not only TGF-      –  mediated induction of Th17 cell develop-
ment but also TGF-      –  mediated suppression of IL-21  –
    producing CD4  +   T cells were reduced in Smad3      /      CD4  +   
T cells compared with those in littermate WT mice.   These 
results indicate that TGF-     signaling induces Th17 cell devel-
opment, but inhibits the development of IL-21  –  producing 
CD4  +   T cells, in part via Smad3-dependent pathways. 
  IL-2 does not inhibit the development of IL-21  –  producing 
CD4  +   T cells 
  It has recently been reported that IL-2 signaling via STAT5 
inhibits the development of Th17 cells (  26  ). We next exam-
ined the role of IL-2 in the development of IL-21  –  producing 
CD4  +   T cells. When naive CD4  +   T cells were stimulated 
with anti-CD3 mAb/anti-CD28 mAb in the presence of 
IL-6, anti  –  IL-4 mAb, and anti  –  IFN-     mAb, neither IL-2 
nor anti  –  IL-2 mAb signifi  cantly aff  ected the development of 
IL-21  –  producing CD4  +   T cells (  Fig. 6  ).   On the other hand, 
Th2-polarizing conditions (unpublished data). In contrast, 
consistent with previous reports (  20  –  22  ), TGF-     together 
with IL-6 induced the development of IL-17A  –   and IL-17F  –
  producing Th17 cells (  Fig. 3 A  ). These results indicate that 
IL-6 induces the development of IL-21  –  producing CD4  +   
T cells, but on the contrary, TGF-     inhibits IL-6  –  induced 
development of IL-21  –  producing CD4  +   T cells. 
  We next examined the kinetics of IL-21, -17A, and -17F 
production from naive CD4  +   T cells upon stimulation with 
anti-CD3 mAb/anti-CD28 mAb. In the presence of IL-6, 
anti  –  IL-4 mAb, and anti  –  IFN-     mAb, IL-21  –  producing 
CD4  +   T cells were detected at a low frequency at day 1 after 
stimulation, and then the frequency of IL-21  –  producing 
CD4  +   T cells was increased until day 4 in a time-dependent 
manner without the production of IL-17A and -17F (  Fig. 4  ).   
Under Th17-polarizing conditions, IL-21  –  producing CD4  +   
T cells were also detected at day 1, but the frequency of 
IL-21  –  producing CD4  +   T cells was not increased thereafter 
(  Fig. 4  ). On the other hand, IL-17A  –  producing CD4  +   T cells 
were detected at day 2 under Th17-polarizing conditions 
(  Fig. 4  ). IL-17F  –  producing CD4  +   T cells were also detected 
at day 2 under Th17-polarizing conditions and were in-
creased at day 4 (  Fig. 4  ). 
    Figure 4.     Kinetics of IL-21 production from CD4  +   T cells.  Naive 
CD4  +   T cells from C57BL/6 mice were stimulated with anti-CD3 mAb/anti-
CD28 mAb in the presence of anti  –  IL-4 mAb and anti  –  IFN-     mAb  (neutral 
condition) with 100 ng/ml IL-6 or IL-6 plus 1 ng/ml TGF-    . At indicated 
times after stimulation, cells were stimulated with PMA/ionomycin, and 
intracellular staining for the indicated cytokines was performed. Shown 
are representative FACS profi  les from three independent experiments.     
    Figure 5.     Smad3 is involved in TGF-      –  mediated suppression of 
IL-21 production from CD4  +   T cells.  Purifi  ed CD4  +   T cells from Smad3     /    
mice or littermate WT mice were stimulated with anti-CD3 mAb/anti-
CD28 mAb in the presence of anti  –  IL-4 mAb, anti  –  IFN-     mAb, and anti  –
  IL-2 mAb with 100 ng/ml IL-6 or IL-6 plus 1 or 5 ng/ml TGF-     for 3 d. 
Cells were then stimulated with PMA/ionomycin and intracellular staining 
for IL-21 versus IL-17A was performed. Shown are representative FACS 
profi  les from three independent experiments.     JEM VOL. 205, June 9, 2008 
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presence of IL-6, anti  –  IL-4 mAb, and anti  –  IFN-     mAb and 
under Th17-polarizing conditions by 20  –  30% (  Fig. 7 B  ). 
These results suggest that IL-21 and -6 both induce the 
development of IL-21  –  producing CD4  +   T cells, the eff  ect of 
the latter of which is mediated in part by IL-21 production. 
  In contrast, the blockade of IL-21 signaling by soluble 
IL-21R-Fc resulted in the decreased development of Th17 
cells (  Fig. 7 B  ), which is consistent with previous reports 
(  6  –  9  ). Together with our fi  nding that a considerable number of 
IL-21  –  producing CD4  +   T cells are negative for intracellular 
IL-17A and -17F under Th17-polarizing conditions (  Fig. 2  ), 
these results suggest that IL-21 functions not only as an auto-
crine growth factor but also as a paracrine growth factor for 
the development of Th17 cells. 
  We also examined the eff  ect of anti  –  IL-6 antibody on the 
diff  erentiation of IL-21  –  producing CD4  +   T cells from naive 
CD4  +   T cells cultured under Th2-polarizing conditions. As 
shown in   Fig. 7 C  , a neutralizing antibody against IL-6 
decreased the number of IL-21  –  producing CD4  +   T cells by 
50% without any signifi  cant change in the number of IL-4 
single-positive cells. Moreover, although soluble IL-21R-Fc 
itself did not signifi  cantly decrease the number of IL-21  –
  producing CD4  +   T cells under Th2-polarizing conditions 
(unpublished data), IL-21R-Fc together with anti  –  IL-6 anti-
body signifi  cantly suppressed the diff  erentiation of IL-21  –
  producing CD4  +   T cells under Th2-polarizing conditions to 
a greater extent than anti  –  IL-6 antibody alone (  Fig. 7 C  ). 
These results suggest that during Th2 cell diff  erentiation, 
IL-6 produced by Th2 cells promotes the diff  erentiation of 
IL-21  –  producing CD4  +   T cells from Th2 cells and non-Th2 
CD4  +   T cells. 
  Expression of transcription factors in CD4  +   T cells cultured 
in the presence of IL-6 
  We also examined the expression pattern of transcription fac-
tors in CD4  +   T cells that were cultured in the presence of 
IL-6, anti  –  IL-4 mAb, and anti  –  IFN-     mAb. Consistent with 
previous reports (  5  ), CD4  +   T cells cultured under Th17-
  polarizing conditions expressed ROR    t, but not Foxp3, T-bet, 
or GATA3 (  Fig. 8  ).   In contrast, CD4  +   T cells cultured in the 
presence of IL-6, anti  –  IL-4 mAb, and anti  –  IFN-     mAb ex-
pressed a moderate level of ROR    t, but not Foxp3, T-bet, 
or GATA3 (  Fig. 8  ). As expected, Th1 cells expressed T-bet, 
Th2 cells expressed GATA3, and regulatory T (T reg) cells 
expressed Foxp3 (  Fig. 8  ). 
  The frequency of IL-21  –  producing cells is increased 
with the rounds of cell cycle progression 
  It has been shown that the production of cytokines such as 
IL-4 is correlatively increased in CD4  +   T cells with cell divisions 
(  27, 28  ). We next examined the correlation of IL-21 produc-
tion and cell cycle progression of CD4  +   T cells using a CFSE-
labeling method. As shown in   Fig. 9  , the frequency of cell 
division was indistinguishable in CD4  +   T cells cultured in the 
presence of IL-6, anti  –  IL-4 mAb, and anti  –  IFN-     mAb and 
  under Th17-polarizing conditions, IL-2 signifi  cantly enhanced 
the development of IL-21  –  producing CD4  +   T cells (  Fig. 6  ). 
In contrast, IL-17A  –   and IL-17F  –  producing CD4  +   T cells were 
decreased by IL-2 and were increased by anti  –  IL-2 mAb un-
der Th17-polarizing conditions (  Fig. 6  ), which is consistent 
with the previous study showing that the genetic deletion 
or antibody blockade of IL-2 promotes the diff  erentiation 
of IL-17A  –  producing CD4  +   T cells (  26  ). These results suggest 
that, in contrast to the development of Th17 cells, IL-2 instead 
exerts an enhancing eff  ect on the development of IL-21  –
  producing CD4  +   T cells under Th17-polarizing conditions. 
  IL-21 functions as an autocrine growth factor 
for IL-21  –  producing CD4  +   T cells 
  It was recently reported that IL-21 functions as an autocrine 
growth factor for the development of Th17 cells (  6  –  9  ). We 
determined the role of IL-21 on the development of IL-21  –
  producing CD4  +   T cells. IL-21, in the presence of the block-
ing antibodies to IL-4 and IFN-    , induced the development 
of IL-21  –  producing CD4  +   T cells from WT CD4  +   T cells, 
but not from IL-21R  –  defi  cient (IL-21R      /     ) CD4  +   T cells 
(  Fig. 7 A  ).   In addition, IL-21  –  induced development of IL-
21  –  producing CD4  +   T cells was inhibited by TGF-     (  Fig. 
7 A  ), like IL-6  –  induced development was (  Fig. 3  ). Soluble 
IL-21R-Fc, which neutralizes IL-21 (  10  ), also inhibited the 
development of IL-21  –  producing CD4  +   T cells both in the 
    Figure 6.     IL-2 does not inhibit the development of IL-21  –  produc-
ing CD4  +   T cells.   Naive  CD4 +   T cells from C57BL/6 mice were stimulated 
with anti-CD3 mAb/anti-CD28 mAb in the presence of anti  –  IL-4 mAb and 
anti – IFN-    mAb with 100 ng/ml IL-6 or IL-6 plus 1 ng/ml TGF-   .  Where 
indicated, either 10 ng/ml IL-2 or 10   μ  g/ml anti  –  IL-2 antibody was added 
to the culture. 4 d later, cells were stimulated with PMA/ionomycin and 
intracellular staining for the indicated cytokines was performed. Shown 
are representative FACS profi  les from three independent experiments.     1374 CHARACTERIZATION OF IL-21  –  PRODUCING HELPER T CELLS | Suto et al.
under Th17-polarizing conditions.   IL-21  –  producing CD4  +   T 
cells were observed in all rounds of cell cycle progression in 
the presence of IL-6, anti  –  IL-4 mAb, and anti  –  IFN-     mAb, 
but the frequency of IL-21  –  producing cells was increased 
with the rounds of cell cycle progression (  Fig. 9  ). Similarly, 
under Th17-polarizing conditions, IL-17A  –   and IL-17F  –
  producing cells were observed in all rounds of cell cycle pro-
gression, but the frequency of them was also increased with 
the rounds of cell cycle progression (  Fig. 9  ). 
  IL-21  –  producing CD4  +   T cells do not lose the ability 
to produce IL-21 when they are restimulated under Th1- 
or Th2-polarizing conditions 
  Fully diff  erentiated Th1 cells and Th2 cells exhibit a stable 
phenotype regarding the pattern of cytokine production (  29, 
30  ). Finally, we examined whether IL-21  –  producing CD4  +   
T cells exhibited a stable phenotype of IL-21 production. To 
address this issue, CD4  +   T cells were stimulated with anti-
CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti  –
  IL-4 mAb, and anti  –  IFN-     mAb twice, at a 5-d interval, and 
IL-21 production was assessed by intracellular staining after 
restimulation with anti-CD3 mAb. As shown in   Fig. 10 A   
(top), IL-21  –  producing CD4  +   T cells did not lose their abil-
ity to produce IL-21 at 10 d and did not produce a signifi  -
cant amount of IFN-    , IL-4, or IL-17A.   This stable 
phenotype of IL-21  –  producing CD4  +   T cells was observed 
at least for 20 d of culture (unpublished data). We also exam-
ined whether IL-21  –  producing CD4  +   T cells exhibited a 
stable phenotype against Th1, Th2, or Th17 polarization. 
After CD4  +   T cells were stimulated with anti-CD3 mAb/
anti-CD28 mAb in the presence of IL-6, anti  –  IL-4 mAb, 
and anti  –  IFN-     mAb for 5 d, these cells were restimulated 
under Th1-, Th2-, or Th17-polarizing conditions for 5 d. 
As shown in   Fig. 10 A   (bottom), IL-21  –  producing CD4  +   
T cells that were restimulated under Th1-polarizing condi-
tions produced IL-21, but not IFN-    , indicating that IL-21  –
  producing CD4  +   T cells are stable against Th1 polarization. 
In contrast, when IL-21  –  producing CD4  +   T cells were re-
stimulated under Th2-polarizing conditions, a considerable 
population of cells produced both IL-21 and -4 (  Fig. 10 A  ), 
suggesting that IL-21  –  producing CD4  +   T cells may have a 
potential for IL-4 production. When IL-21  –  producing 
CD4  +   T cells were restimulated under Th17-polarizing 
conditions, IL-21  –  producing CD4  +   T cells were decreased 
and IL-17A  –  producing cells were increased (  Fig. 10 A  ), sug-
gesting that IL-21  –  producing CD4  +   T cells may also have 
a potential for the diff  erentiation of Th17 cells. Collec-
tively, these results indicate that IL-21  –  producing CD4  +   
T cells exhibit a stable phenotype of IL-21 production in 
the presence of IL-6, but may still have a potential for IL-4 
and -17A production. 
    Figure 7.     IL-21 induces the development of IL-21  –  producing CD4  +   
T cells.   (A) Naive CD4  +   T cells from IL-21R     /     mice or littermate WT mice 
on a BALB/c background were stimulated with anti-CD3 mAb/anti-CD28 
mAb in the presence of anti  –  IL-4 mAb and anti  –  IFN-     mAb (neutral con-
dition) with 100 ng/ml IL-21 or 1 ng/ml IL-21 plus TGF-    . 4 d later, cells 
were stimulated with PMA/ionomycin and intracellular staining for IL-21 
versus IL-17A was performed. Shown are representative FACS profi  les 
from three independent experiments. (B) Naive CD4  +   T cells from BALB/c 
mice were stimulated with anti-CD3 mAb/anti-CD28 mAb for 4 d in the 
presence of anti  –  IL-4 mAb and anti  –  IFN-     mAb with IL-6 or IL-6 plus 
TGF-    . Where indicated, soluble IL-21R-Fc (10   μ  g/ml) was added. Cells 
were stimulated with PMA/ionomycin and intracellular staining for IL-21 
versus IL-17A was performed. Shown are representative FACS profi  les 
from three independent experiments. (C) Naive CD4  +   T cells from C57BL/6 
mice were stimulated with anti-CD3 mAb/anti-CD28 mAb under Th2-
polarizing conditions for 5 d. Where indicated, a neutralizing antibody 
against 10   μ  g/ml IL-6 and/or soluble IL-21R-Fc were added. Cells were 
then stimulated with PMA/ionomycin and intracellular staining for the 
indicated cytokines was performed. Shown are representative FACS pro-
fi  les from three independent experiments.     
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  IL-21 was originally reported to be a product of activated 
CD4  +   T cells (  10  ). Subsequently, it has been shown that 
among CD4  +   T cells, Th2 cells but not Th1 cells produce 
IL-21 (  13  ). More recently, it has been demonstrated that 
Th17 cells produce higher levels of IL-21 than Th2 cells and 
that IL-21 functions as an autocrine growth factor for Th17 
cells (  6  –  9  ). However, all of these fi  ndings were based on the 
analysis on a mixed population of CD4  +   T cells because there 
has been no single-cell analysis for IL-21 production available 
as yet. In this study, we have established the intracellular cy-
tokine staining of IL-21 and have shown that a considerable 
number of IL-21  –  producing CD4  +   T cells under Th17-
polarizing conditions are negative for intracellular IL-17A and 
-17F (  Figs. 2 and 3  ), providing a new insight into the cellular 
source of IL-21 in activated CD4  +   T cells. 
  We show that IL-6 and -21 both potently induce the de-
velopment of IL-21  –  producing CD4  +   T cells (  Figs. 3 and 7  ). 
In addition, IL-6  –  induced development of IL-21  –  producing 
CD4  +   T cells is mediated in part by IL-21 production be-
cause IL-6  –  induced development of IL-21  –  producing CD4  +   
T cells was modestly, but reproducibly, decreased by the 
neutralization of IL-21 (  Fig. 7  ). In a preliminary study, we 
also found that IL-21 enhanced the survival of IL-21  –  pro-
ducing CD4  +   T cells (unpublished data). These results sug-
gest that IL-21 may function as an autocrine growth factor 
for IL-21  –  producing CD4  +   T cells. In contrast, because IL-21 
induces Th17 cell development (  Fig. 7 A  ) (  6  –  9  ), and because 
a considerable number of IL-21  –  producing CD4  +   T cells 
    DISCUSSION   
  In this study, we investigated the diff  erentiation and charac-
teristics of IL-21  –  producing CD4  +   T cells. By the newly de-
veloped intracellular staining of IL-21, we found that although 
IL-21  –  producing CD4  +   T cells developed preferentially un-
der Th17-polarizing conditions, a considerable number of 
IL-21  –  producing CD4  +   T cells were negative for intracellu-
lar IL-17A and -17F (  Fig. 2  ). We also found that IL-6 strongly 
induced the development of IL-21  –  producing CD4  +   T cells 
without the induction of IL-4, IFN-    , IL-17A, and IL-17F 
production (  Fig. 3  ). Furthermore, TGF-     inhibited the 
IL-6-induced development of IL-21  –  producing CD4  +   T cells 
in a dose-dependent manner (  Fig. 3  ). In contrast, consistent 
with previous reports (  20  –  22  ), TGF-     together with IL-6 
induced the development of Th17 cells (  Fig. 3  ). IL-21 itself 
also induced the development of IL-21  –  producing CD4  +   T 
cells from WT CD4  +   T cells, but not from IL-21R      /      CD4  +   
T cells (  Fig. 7  ). In addition, IL-21  –  induced development of 
IL-21  –  producing CD4  +   T cells was inhibited by TGF-     
(  Fig. 7  ), like IL-6  –  induced development was (  Fig. 3  ). Finally, 
CD4  +   T cells cultured in the presence of IL-6 expressed a 
moderate level of ROR    t, but not Foxp3, T-bet, or GATA3 
(  Fig. 8  ), and exhibited a stable phenotype of IL-21 produc-
tion (  Fig. 10  ). Collectively, these results suggest that IL-21  –
  producing CD4  +   T cells exhibit distinct characteristics from 
Th17 cells, that IL-21  –  producing CD4  +   T cells develop pref-
erentially in an IL-6  –  rich environment devoid of TGF-    , 
and that IL-21 functions as an autocrine growth factor for 
IL-21  –  producing CD4  +   T cells. 
    Figure 8.     Expression of transcription factors in CD4  +   T cells cul-
tured in the presence of IL-6.   Naive  CD4 +   T cells from C57BL/6 mice 
were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of 
anti – IL-4  mAb  and  anti – IFN-    mAb with IL-6, IL-6 plus TGF-    , or TGF-    
alone for 60 h. As controls, naive CD4  +   T cells were stimulated with anti-
CD3 mAb/anti-CD28 mAb under Th1-polarizing conditions or Th2-polar-
izing conditions for 60 h. The expression of ROR    t, Foxp3, T-bet, and 
GATA3 was assessed by real-time PCR. Data are representative of three 
independent experiments.     
    Figure 9.     The frequency of IL-21  –  producing cells is increased with 
the rounds of cell cycle progression.   Naive CD4  +   T cells from C57BL/6 
mice were labeled with CFSE, stimulated with anti-CD3 mAb/anti-CD28 
mAb in the presence of anti  –  IL-4 mAb and anti  –  IFN-     mAb (neutral con-
dition) with IL-6 or IL-6 plus TGF-     for 4 d. Cells were stimulated with 
PMA/ionomycin and intracellular staining for IL-21, -17A, and -17F was 
performed. Shown are representative FACS profi  les from three indepen-
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but not of IL-21  –  producing CD4  +   T cells (  Fig. 6  ). These 
fi  ndings suggest that the development of IL-21  –  producing 
CD4  +   T cells, Th17 cells, and T reg cells is reciprocally regu-
lated by the balance among IL-6 plus IL-21, TGF-    , and IL-2 
in an environment. 
  Molecular mechanisms underlying the development of 
IL-21  –  producing CD4  +   T cells remain to be elucidated. We 
show that IL-6 and -21, both of which use STAT3 as a sig-
naling molecule (  11, 12, 32  ), induce the development of 
IL-21  –  producing CD4  +   T cells (  Figs. 3 and 7  ). It has also been 
reported that under Th17-polarizing conditions, IL-21 pro-
duction is induced by a STAT3-dependent mechanism, but 
not a ROR    t-dependent mechanism (  6, 7  ), suggesting that 
STAT3 is critical for the development of IL-21  –  producing 
CD4  +   T cells. Because IL-6 up-regulates NFAT transcrip-
tional activity by increasing the levels of NFATc2 (  33  ), and 
because NFATc2 activates IL-21 promoter (  34  ), it is also 
plausible that IL-6  –  mediated activation of NFATc2 is in-
volved in the induction of IL-21 gene expression. Because 
Foxp3, which is induced by TGF-      –  mediated signaling (  31, 
35  ), interacts with NFAT and down-regulates NFAT activity 
(  36  –  38  ), TGF-     may suppress the development of IL-21  –
  producing CD4  +   T cells (  Fig. 3  ) by producing Foxp3  –
  NFATc2 complexes. 
  Recently, it has been shown that IL-22 is expressed in 
CD4  +   T cells under Th17-polarizing conditions (  6, 39, 40  ) 
and that it mediates IL-23  –  induced dermal infl  ammation and 
hyperplasia of the epidermis in psoriasis (  40  ). Interestingly, 
similar to IL-21, IL-22 is induced by IL-6 but is inhibited by 
TGF-     (  40  ). In contrast, IL-17A and -17F are expressed in 
the presence of IL-6 and TGF-     (  Fig. 3  ) (  41, 42  ). However, 
at present, it is still unknown whether IL-21  –  producing 
CD4  +   T cells do produce IL-22 together. The detailed analy-
sis of autoimmune disease models in IL-21  –  defi  cient mice, 
IL-17A/IL-17F double-defi  cient mice, and IL-17A/IL-17F/
IL-21 triple-defi  cient mice may provide evidence for a non-
redundant role of IL-21  –  producing CD4  +   T cells and IL-
17A/IL-17F  –  producing CD4  +   T cells in the pathogenesis of 
autoimmune diseases. 
  Regarding the phenotypic stability of IL-21  –  producing 
CD4  +   T cells, we found that IL-21  –  producing CD4  +   T cells 
could produce IL-21 for at least 20 d of culture (  Fig. 10   and 
not depicted). We also found that IL-21  –  producing CD4  +   T 
cells did not lose their ability to produce IL-21 even when 
they were restimulated under Th1- or Th2-polarizing condi-
tions (  Fig. 10  ). Interestingly, IL-21  –  producing CD4  +   T cells 
still had a potential to produce IL-4 when IL-21  –  producing 
CD4  +   T cells were restimulated under Th2-polarizing condi-
tions, whereas IL-21  –  producing CD4  +   T cells did not pro-
duce IFN-     even when IL-21  –  producing CD4  +   T cells were 
restimulated under Th1-polarizing conditions (  Fig. 10  ). 
These results indicate that IL-21  –  producing CD4  +   T cells 
exhibit a stable phenotype of IL-21 production and the si-
lencing of IFN-     production. This is consistent with our 
previous fi  nding that IL-21 inhibits IFN-     production in de-
veloping Th1 cells through the repression of Eomesodermin 
  under Th17-polarizing conditions are negative for IL-17A 
and -17F (  Figs. 2 and 3  ), it is suggested that IL-21 functions 
on Th17 cells not only as an autocrine growth factor but also 
as a paracrine growth factor. 
  Our results indicate that the developmental characteristic 
of IL-21  –  producing CD4  +   T cells is diff  erent from that of 
Th17 cells, although both T cells require IL-6 and/or IL-21 
for their development (  Figs. 3 and 7  ) (  6  –  9  ). We demonstrate 
that TGF-     inhibits IL-6  –   and IL-21  –  induced development 
of IL-21  –  producing CD4  +   T cells (  Figs. 3, 4, and 7  ). In con-
trast, both IL-6 and TGF-     are required for the development 
of Th17 cells (  Fig. 3  ) (  20  –  22  ). On the other hand, it has been 
shown that TGF-     induces, but IL-6 inhibits, the develop-
ment of Foxp3-expressing regulatory T cells (  20, 31  ). In ad-
dition, IL-2 signaling inhibits the development of Th17 cells, 
    Figure 10.     IL-21  –  producing CD4  +   T cells do not lose their ability 
to produce IL-21 when they are restimulated under Th1- or Th2-
polarizing conditions.   (A)  Purifi  ed CD4  +   T cells from C57BL/6 mice were 
stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of anti  –
  IL-4 mAb and anti  –  IFN-     mAb with IL-6 for 5 d. Cells were restimulated 
for another 5 d under the same condition (top) or Th1-, Th2-, or Th17-
polarizing conditions (bottom). On day 10, cells were stimulated with 
anti-CD3 mAb and intracellular staining for indicated cytokines was per-
formed. Shown are representative FACS profi  les from three independent 
experiments. (B) As positive controls, CD4  +   T cells from C57BL/6 mice were 
stimulated with anti-CD3 mAb/anti-CD28 mAb under Th1-, Th2-, or 
Th17-polarizing conditions for 5 d. Cells were restimulated under the 
same conditions for another 5 d. On day 10, cells were stimulated 
with anti-CD3 mAb and intracellular staining for indicated cytokines 
was performed.     JEM VOL. 205, June 9, 2008 
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purchased from BD Biosciences. Murine IL-2, -4, -6, and -12 were pur-
chased from PeproTech. Human TGF-    , murine IL-21, murine IL-23, IL-
21R-Fc chimera, and anti  –  IL-2 antibody (JES6-1A12) were purchased from 
R  &  D Systems. 
  Cell isolation.     CD44  low   CD25        CD4  +   naive T cells were isolated from 
lymph nodes of mice, as previously described (  40  ), with minor modifi  ca-
tions. In brief, CD4  +   T cells were collected from lymph nodes of mice using 
CD4  +   T cell isolation kit according to the manufacturer  ’  s instructions 
(Miltenyi Biotec). Purifi  ed CD4  +   T cells were stained with anti-CD44 mAb 
and anti-CD25 mAb, and CD44  low   CD25        cells were sorted on a FACSAria 
cell sorter (BD Biosciences). In the experiments shown in   Fig. 1 A  ,   Fig. 5  , and 
  Fig. 10  , CD4  +   T cells were purifi  ed from lymph nodes of mice by EasySep 
mouse CD4  +   T cell enrichment kit (StemCell Technologies, Inc.) using an 
automated cell separator RoboSep (StemCell Technologies, Inc.). In both cases, 
the resultant cells were   >  98% pure CD44  low   CD25        CD4  +   T cells or CD4  +   
T cells, respectively, by FACS analysis. 
  Cell culture.     Naive CD4  +   T cells or purifi  ed CD4  +   T cells were stimulated 
with 1   μ  g/ml plate-bound anti-CD3 mAb at 0.5  –  10  6   cells/ml in the presence 
of 1   μ  g/ml anti-CD28 mAb in a 48-well plate. Where indicated, cells were 
cultured under either Th1-polarizing conditions (10 ng/ml IL-2, 1 ng/ml 
IL-12, and 10   μ  g/ml anti  –  IL-4 mAb), Th2-polarizing conditions (10 ng/ml 
IL-2 and -4 and 10   μ  g/ml anti  –  IFN-     mAb), or Th17-polarizing conditions 
(100 ng/ml IL-6, and 1 ng/ml TGF-    , anti  –  IL-4 mAb, and anti  –  IFN-     
mAb). When cells were cultured for   >  4 d, 20 ng/ml IL-23 was added under 
Th17-polarizing conditions. Where indicated, 100 ng/ml IL-6, 0.2  –  5 ng/ml 
TGF-    , 10 ng/ml IL-2, 100 ng/ml IL-21, 10   μ  g/ml anti  –  IL-2 mAb, 10   μ  g/
ml anti  –  IL-6 mAb, or 10   μ  g/ml IL-21R-Fc was added to the culture. 
  Retrovirus transduction.     Bicistronic retrovirus vector pMX-IRES-GFP 
was a gift from T. Kitamura (Tokyo University, Tokyo, Japan). The IL-21 
cDNA was amplifi  ed by PCR and cloned into pMX-IRES-GFP (IL-21-
IRES-GFP). The production of retroviruses and infection to Ba/F3 cells 
were performed as previously described (  43  ). 
  Intracellular cytokine analysis for IL-21.     Cultured cells were washed 
and restimulated with 20 ng/ml PMA (Calbiochem) plus 1   μ  g/ml ionomycin 
(Calbiochem) or plate-bound anti-CD3 mAb at 37  °  C for 5 h in the presence 
of 2   μ  M monensin (Sigma-Aldrich). Cells were fi  xed, permeabilized with 
Perm/Wash buff  er (BD Biosciences), and incubated with IL-21R/Fc chi-
mera for 30 min at 4  °  C. Cells were then washed with Perm/Wash buff  er and 
stained with PE-conjugated affi   nity-purifi  ed F(ab  ’  )2 fragment of goat anti  –
  human Fc     antibody (anti-Fc PE; Jackson ImmunoResearch Laboratories) 
for 30 min at 4  °  C. Cells were washed twice and stained with anti-CD4 FITC 
and anti  –  IL-4 allophycocyanin (BD Biosciences), anti  –  IFN-     allophycocya-
nin (BD Biosciences), anti  –  IL-17A Alexa Fluor 647 (eBioscience), or anti  –
  IL-17F Alexa Fluor 647 (eBioscience). Cytokine profi  le on CD4  +   cells was 
analyzed on a FACSCalibur using CellQuest Pro software (BD Biosciences). 
Intracellular cytokine staining for IL-4 versus IFN-     was performed using 
anti  –  IL-4 PE (BVD4-1D11; BD Biosciences) and anti  –  IFN-     allophycocya-
nin (XMG1.2, BD Biosciences) as previously described (  43  ). 
  Real-time PCR analysis.     Total cellular RNA was extracted with TRIzol 
solution (Invitrogen). Reverse transcription was performed using an iScript 
cDNA synthesis kit (BioRad Laboratories). Primers and TaqMan probes for 
T-bet, GATA3, ROR    t, Foxp3, and     -actin have been previously de-
scribed (  5, 6, 41, 43  ). Quantitative PCR was performed with an ABI PRISM 
7300 sequence detection system (Applied Biosystems). The levels of T-bet, 
GATA3, ROR    t, or Foxp3 mRNA were normalized to the levels of     -ac-
tin mRNA. 
  ELISA.     The amount of IL-4 and IFN-     in the culture supernatant was 
measured by ELISA kits from BD Bioscience. The amount of IL-17A and -21 
in the culture supernatant was measured by ELISA kits from R  &  D Systems. 
expression (  43  ). In contrast, when IL-21  –  producing CD4  +   T 
cells were restimulated under Th17-polarizing conditions, 
their ability to produce IL-21 was decreased and IL-17A  –
  producing cells were increased (  Fig. 10  ). Therefore, IL-21  –
  producing CD4  +   T cells still have a potential for IL-4 and 
-17A production. 
  It has recently been shown that a subset of CD4  +   T cells, 
termed follicular B helper T cells (TFH cells), produce a large 
amount of IL-21 (  14  ). TFH cells are distinguishable from other 
CD4  +   T cell populations by several criteria, including its loca-
tion in B cell follicles and the expression of chemokine receptor 
CXCR5, and provide a helper function to B cells (  14  ). In pre-
liminary experiments, we found that CD4  +   T cells cultured in 
the presence of IL-6 were negative for CXCR5 expression (un-
published data). Therefore, although further studies are required, 
it is suggested that IL-21  –  producing CD4  +   T cells described in 
the present study seem to be diff  erent from TFH cells. The 
comparative analysis of their helper function to B cells, as well as 
the regulatory mechanism of IL-21 production, is required to 
further address the relationship between these populations. 
  We found that TGF-      –  mediated suppression of IL-21 
production was reduced in Smad3      /      CD4  +   T cells com-
pared with that in WT CD4  +   T cells (  Fig. 5  ). We also found 
that TGF-      –  mediated induction of Th17 cells was reduced 
in Smad3      /      CD4  +   T cells (  Fig. 5  ). These results indicate 
that TGF-      –  Smad3 signaling is involved not only in the 
induction of Th17 cell development but also in the suppres-
sion of IL-21  –  producing CD4  +   T cells. Interestingly, how-
ever, the inhibitory eff  ects of TGF-     were still observed in 
Smad3      /      CD4  +   T cells (  Fig. 5  ). This is consistent with a 
previous study showing that TGF-     exhibits partial eff  ects on 
Smad3      /      CD4  +   T cells (  44  ). Because the molecular func-
tions of Smad3 are somewhat overlapping to Smad2 (  23, 24  ), 
it is suggested that TGF-    exhibits partial eff  ects on Smad3      /      
CD4  +   T cells by using Smad2 as a partner of Smad4. 
  In conclusion, we have shown that IL-6 and -21 prefer-
entially induce the diff  erentiation of IL-21  –  producing CD4  +   
T cells and that the diff  erentiation of IL-21  –  producing CD4  +   
T cells and Th17 cells is diff  erently regulated by TGF-     and 
IL-2. Although further studies are required to address the 
physiological importance of IL-21  –  producing CD4  +   T cells 
in vivo, our results should add a new insight into the regula-
tory mechanism of helper T cell diff   erentiation and the 
pathogenesis of autoimmune diseases. 
    MATERIALS AND METHODS   
  Mice.     BALB/c mice and C57BL/6 mice were purchased from Charles 
River Laboratories. IL-21R  –  defi  cient (IL-21R      /     ) mice (  45  ) on a BALB/c 
background and Smad3      /      mice (  46  ) on a C57BL/6 background (provided 
by S. Honjo, M. Fujimoto, K. Kobayashi, and A. Sakamoto, Chiba Univer-
sity, Chiba, Japan) were described previously. All mice were housed in 
microisolator cages under specifi  c pathogen-free conditions and animal 
procedures used in this study were approved by the Chiba University Ani-
mal Care and Use Committee. 
  Reagents.     Antibodies to CD3 (145-2C11), CD25 (PC61), CD28 (37.51), 
CD44 (IM7), IL-4 (11B11), IL-6 (MP5-20F3), and IFN-     (XMG1.2) were 1378 CHARACTERIZATION OF IL-21  –  PRODUCING HELPER T CELLS | Suto et al.
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